And we’re live! ✨ @HUISHANLI1 and I are proud to have led this research under @MoKhalilLab’s leadership, and with support from an amazing team of collaborators. Check out Mo’s super thread here👇🏼
Synthetic circuits that program new capabilities into human cells have tremendous potential to expand emerging gene and cell-based therapies. Our latest work, out today in @ScienceMagazine, reports a platform to accelerate these developments: (1/n)
science.org/doi/10.1126/scie…
Divya Israni retweeted
Yesterday was a historic day in plant biotech: a purple tomato engineered with high antioxidants was approved by @USDA @BigPurpleTomato helps prevent cardiovascular disease and fight cancer in humans.
This approval under new regulation ushers in a new era for plant synbio!
Excited to be part of the Satellite Bio team! Our company has officially unveiled with more than $110 million in financing to pioneer Tissue Therapeutics, a new category of regenerative medicine. Onwards and upwards 🚀 businesswire.com/news/home/2…
Divya Israni retweeted
Excited to share our paper @CellCellPress tinyurl.com/22s9pztn. Ray Liu and Iowis Zhu led the development of clinically optimized and tunable nextgen synNotch receptors dubbed SNIPRs for cell therapies. Thank you @UCSF @GladstoneInst @parkerici press: tinyurl.com/2p8usz7z
Divya Israni retweeted
My experiences in Dr. Ting Lu's lab documented in the letter attached.
It's not about him. I've cared about him enough during those 18 months of my life. It's about the students.
@UofIllinois @geo_uiuc @TheDailyIllini @uofigrainger @Nature
drive.google.com/file/d/1G_0…
love when people accidentally write “complimentary DNA strands” 😊🧬
This Post is from an account that no longer exists. Learn more
Divya Israni retweeted
Therapeutic mRNA for heart failure?!
Our own Joel Rurik (@DevBioAcademic) teamed up with @WeissmanLab to make CAR T cells entirely in the body to treat heart disease.
Published today on the cover of Science!
science.org/doi/10.1126/scie…
@CAMBUpenn @PennBGS @ScienceMagazine
1/6
Divya Israni retweeted
In 2020, we introduced the Inclusivity Award to recognize excellence among iGEM teams working to create a more inclusive and representative scientific community. Meet last year's winners, and find out which past projects inspired the creation of the award. bit.ly/2YOY59O
Divya Israni retweeted
Apply to Speak at @SynBioAfrica conference.
SynBio Africa is organizing the first face-to-face international #synthetic biology and #biosecurity #conference in #Africa in October 14-16, 2021 at Hotel Africana, Uganda.
Follow the link below to apply.
lnkd.in/dJkHEqh
Divya Israni retweeted
Excited to share new work w/ co-lead @CamilliaAzimi, @MarsonLab @kickassscience1 @roybal_lab: using a method we call 'CAR Pooling', we tested many CARs in multiplex & found new non-T cell signaling domains which improve CAR-T efficacy. biorxiv.org/cgi/content/shor… 👇🧵 1/10
Divya Israni retweeted
'There have been many definitions of synthetic biology over the years, but I especially like the definition offered by my friend and colleague, @meganjpalmer “Synthetic biology is a community, a field, and an approach”.'
New #iGEMBlog by @MeaganLizarazo
blog.igem.org/blog/2021/6/2/…
A tremendous effort led by Ray, Iowis, and @KoleRoybal! It has been really amazing to watch these new ideas take shape firsthand, and moreover to help develop humanized SNIPRs compatible with our synthetic ZFs (synZiFTRs)
1/4 Excited to share our new preprint from the @roybal_lab & @MoKhalilLab-Raymond Liu and Iowis Zhu led the development of NextGen synNotch receptors. SynNotch is one ‘species’ in a larger ‘genus’ of SyNthetic Intramembrane Proteolysis Receptors (SNIPRs) tinyurl.com/7kf6bdyr
Divya Israni retweeted
We want to make synthetic biology more accessible everywhere, introduce you to this world, build the next generation of synthetic biologists in Latin America, and make you discover your passion to #DesignWithBiology! Join us in our kick-off event: bit.ly/3n2SrJ8
So thrilled to finally be sharing this preprint with the community! This is a culmination of many years of critical discussion and hard work by a truly exceptional team
1/ Synbio has potential to enhance next-gen therapies, but how can we make clinically-viable, therapeutic circuits in human cells a reality? Excited to unveil 1st of several papers trying to address this question, led by the brilliant @phdivya & Huishan Li
biorxiv.org/content/10.1101/…
Last official day in the Khalil lab for me and @MancusoSci. It’s truly the end of an era, but I’m so deeply grateful for all of the experiences and memories along the way. Sincere thanks, and will miss everyone! @MoKhalilLab, @BioDesignCenter, @BUgradBME
Apply to join us as part of the iGEM Diversity & Inclusion committee! We welcome applicants from all corners of the world who wish to help make iGEM more representative and more inclusive.
The iGEM Diversity & Inclusion Committee is looking for new members in 2021! The committee works to make iGEM as inclusive as possible for people from all different backgrounds. Please apply by Feb 5, 2021. Application: surveymonkey.com/r/iGEMDiver…
Divya Israni retweeted
Introducing the BioMe plate! This modified 96-well microplate enables the observation of microbes interacting across a porous membrane. Very happy to have the paper from my graduate work with @segrelab co-led by Charles Jo (who also made this awesome GIF) out on BioRxiv now!
A co-culture microplate for real-time measurement of microbial interactions biorxiv.org/cgi/content/shor… #bioRxiv
Divya Israni retweeted
As you review those grad school applications "failed iGEM project" is the #1 thing you should look for in your future life scientists. Here's why: